Fumarate Hydratase Variants and Their Association With Paraganglioma/Pheochromocytoma.
Urology
; 176: 106-114, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-36773955
ABSTRACT
OBJECTIVE:
To clarify the link between germline variants in fumarate hydratase (FH), hereditary leiomyomatosis and renal cell cancer (HLRCC), and paraganglioma (PGL) and pheochromocytoma (PCC) we utilize a well-annotated hereditary cancer testing database.METHODS:
Records of 120,061 patients receiving germline testing were obtained. FH variants were classified into 4 categories autosomal dominant (AD) HLRCC variants, autosomal recessive (AR) fumarase deficiency (FMRD), variants, previously reported as PGL/PCC FH variants, and variants of unknown significance (VUS) not previously associated with PGL/PCC (NPP-VUS). Rates of PGL/PCC were compared with those with negative genetic testing.RESULTS:
About 1.3% of individuals carried FH variants which were more common among individuals with PGL/PCC compared to those without (3.1% vs 1.3%, P < .0001). PGL/PCC rates were higher among individuals with PGL/PCC FH variants compared to those with negative genetic testing (22.2% vs 0.9%, P < .0001). Neither AD HLRCC variants (0.3% vs 0.9%, Pâ¯=â¯.35) nor AR FMRD variants (1.4% vs 0.9%, Pâ¯=â¯.19) carried an increased prevalence of PGL/PCC. An increased prevalence of PGL/PCC was detected in those with NPP-VUS (2.0% vs 0.9%, Pâ¯=â¯.0023).CONCLUSIONS:
Certain FH variants confer an increased risk of PGL/PCC, but not necessarily HLRCC. While universal screening for PGL/PCC among all individuals with FH variants does not appear warranted, it should be considered in select high-risk PGL/PCC FH variants.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Paraganglioma
/
Pheochromocytoma
/
Skin Neoplasms
/
Uterine Neoplasms
/
Adrenal Gland Neoplasms
Type of study:
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Urology
Year:
2023
Document type:
Article
Affiliation country: